Annual Short Term Debt
$30.17 M
-$13.35 M-30.68%
December 31, 2022
Summary
- As of February 24, 2025, SRNE annual short term debt is $30.17 million, with the most recent change of -$13.35 million (-30.68%) on December 31, 2022.
- During the last 3 years, SRNE annual short term debt has fallen by -$9.42 million (-23.79%).
- SRNE annual short term debt is now -30.68% below its all-time high of $43.52 million, reached on December 31, 2021.
Performance
SRNE Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$133.41 M
+$69.73 M+109.49%
June 30, 2023
Summary
- As of February 24, 2025, SRNE quarterly short term debt is $133.41 million, with the most recent change of +$69.73 million (+109.49%) on June 30, 2023.
- Over the past year, SRNE quarterly short term debt has increased by +$69.73 million (+109.49%).
- SRNE quarterly short term debt is now at all-time high.
Performance
SRNE Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
SRNE Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.7% | +109.5% |
| 3 y3 years | -23.8% | +109.5% |
| 5 y5 years | - | +109.5% |
SRNE Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.7% | at low | at high | +342.3% |
| 5 y | 5-year | -30.7% | +12.4% | at high | +568.4% |
| alltime | all time | -30.7% | >+9999.0% | at high | >+9999.0% |
Sorrento Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $133.41 M(+109.5%) |
| Mar 2023 | - | $63.69 M(+111.1%) |
| Dec 2022 | $30.17 M(-30.7%) | $30.17 M(-54.5%) |
| Sep 2022 | - | $66.28 M(+78.1%) |
| Jun 2022 | - | $37.22 M(-46.4%) |
| Mar 2022 | - | $69.39 M(+59.5%) |
| Dec 2021 | $43.52 M(+62.2%) | $43.52 M(+11.2%) |
| Sep 2021 | - | $39.13 M(+15.8%) |
| Jun 2021 | - | $33.78 M(+32.7%) |
| Mar 2021 | - | $25.45 M(-5.2%) |
| Dec 2020 | $26.83 M(-32.2%) | $26.83 M(+20.8%) |
| Sep 2020 | - | $22.22 M(-1.7%) |
| Jun 2020 | - | $22.61 M(+13.3%) |
| Mar 2020 | - | $19.96 M(-49.6%) |
| Dec 2019 | $39.58 M(+290.0%) | $39.58 M(+37.0%) |
| Sep 2019 | - | $28.89 M(-16.6%) |
| Jun 2019 | - | $34.66 M(+209.1%) |
| Mar 2019 | - | $11.21 M(+10.5%) |
| Dec 2018 | $10.15 M(+4756.5%) | $10.15 M(-64.0%) |
| Sep 2018 | - | $28.23 M(+1768.4%) |
| Jun 2018 | - | $1.51 M(-5.2%) |
| Mar 2018 | - | $1.59 M(-33.8%) |
| Sep 2017 | - | $2.41 M(+1051.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $209.00 K(-95.7%) | $209.00 K(-96.0%) |
| Sep 2016 | - | $5.19 M(+2.4%) |
| Jun 2016 | - | $5.07 M(+2.4%) |
| Mar 2016 | - | $4.95 M(+2.4%) |
| Dec 2015 | $4.83 M(+45.8%) | $4.83 M(+2.4%) |
| Sep 2015 | - | $4.72 M(+2.4%) |
| Jun 2015 | - | $4.61 M(+1.7%) |
| Mar 2015 | - | $4.54 M(+36.8%) |
| Dec 2014 | $3.32 M(+786.6%) | $3.32 M(-9.3%) |
| Sep 2014 | - | $3.65 M(+40.1%) |
| Jun 2014 | - | $2.61 M(+54.7%) |
| Mar 2014 | - | $1.69 M(+350.8%) |
| Dec 2013 | $374.00 K(+3836.8%) | $374.00 K(+28.1%) |
| Jun 2013 | - | $292.00 K(+9.1%) |
| Mar 2013 | - | $267.60 K(+2716.8%) |
| Sep 2005 | - | $9500.00(0.0%) |
| Jun 2005 | - | $9500.00(0.0%) |
| Mar 2005 | - | $9500.00(0.0%) |
| Dec 2004 | $9500.00(0.0%) | $9500.00(0.0%) |
| Sep 2004 | - | $9500.00(0.0%) |
| Jun 2004 | - | $9500.00(0.0%) |
| Mar 2004 | - | $9500.00 |
| Dec 2003 | $9500.00 | - |
FAQ
- What is Sorrento Therapeutics annual short term debt?
- What is the all time high annual short term debt for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual short term debt year-on-year change?
- What is Sorrento Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly short term debt year-on-year change?
What is Sorrento Therapeutics annual short term debt?
The current annual short term debt of SRNE is $30.17 M
What is the all time high annual short term debt for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual short term debt is $43.52 M
What is Sorrento Therapeutics annual short term debt year-on-year change?
Over the past year, SRNE annual short term debt has changed by -$13.35 M (-30.68%)
What is Sorrento Therapeutics quarterly short term debt?
The current quarterly short term debt of SRNE is $133.41 M
What is the all time high quarterly short term debt for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly short term debt is $133.41 M
What is Sorrento Therapeutics quarterly short term debt year-on-year change?
Over the past year, SRNE quarterly short term debt has changed by +$69.73 M (+109.49%)